News Focus
News Focus
icon url

DewDiligence

03/04/18 6:00 PM

#217664 RE: DewDiligence #217544

RVNC’s pro forma cash balance at 12/31/17=$289.3M. This figure consists of: $264.3M of net current assets on the 12/31/17 balance sheet (https://www.sec.gov/Archives/edgar/data/1479290/000147929018000038/rvnc1231201710k.htm#s4BDE5FBFF06F5892BCA0699CB0E34186 ); and $25M due from MYL pursuant to the companies’ Botox-biosimilar collaboration announced on 2/28/18 (#msg-138919580).
icon url

DewDiligence

05/08/18 4:15 PM

#218919 RE: DewDiligence #217544

RVNC 1Q18 results—cash=$269M:

http://investors.revance.com/releasedetail.cfm?ReleaseID=1066779

CC at 4:30pm ET.